These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22553321)

  • 21. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
    Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
    Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.
    Althaus CL; De Boer RJ
    Proc Biol Sci; 2012 Aug; 279(1740):3003-10. PubMed ID: 22492063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
    Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
    Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms.
    Crawford H; Matthews PC; Schaefer M; Carlson JM; Leslie A; Kilembe W; Allen S; Ndung'u T; Heckerman D; Hunter E; Goulder PJ
    J Virol; 2011 Feb; 85(3):1384-90. PubMed ID: 21106744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.
    Altfeld M; Rosenberg ES; Shankarappa R; Mukherjee JS; Hecht FM; Eldridge RL; Addo MM; Poon SH; Phillips MN; Robbins GK; Sax PE; Boswell S; Kahn JO; Brander C; Goulder PJ; Levy JA; Mullins JI; Walker BD
    J Exp Med; 2001 Jan; 193(2):169-80. PubMed ID: 11148221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.
    Eriksson EM; Liegler T; Keh CE; Karlsson AC; Holditch SJ; Pilcher CD; Loeb L; Nixon DF; Hecht FM
    PLoS One; 2014; 10(4):e0120787. PubMed ID: 25919393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    Jones NA; Wei X; Flower DR; Wong M; Michor F; Saag MS; Hahn BH; Nowak MA; Shaw GM; Borrow P
    J Exp Med; 2004 Nov; 200(10):1243-56. PubMed ID: 15545352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rate of immune escape vanishes when multiple immune responses control an HIV infection.
    van Deutekom HW; Wijnker G; de Boer RJ
    J Immunol; 2013 Sep; 191(6):3277-86. PubMed ID: 23940274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].
    Shi Y; Wan Y; Xu J
    Bing Du Xue Bao; 2015 May; 31(3):299-306. PubMed ID: 26470538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.
    Liu Y; McNevin J; Zhao H; Tebit DM; Troyer RM; McSweyn M; Ghosh AK; Shriner D; Arts EJ; McElrath MJ; Mullins JI
    J Virol; 2007 Nov; 81(22):12179-88. PubMed ID: 17728222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection.
    Henn MR; Boutwell CL; Charlebois P; Lennon NJ; Power KA; Macalalad AR; Berlin AM; Malboeuf CM; Ryan EM; Gnerre S; Zody MC; Erlich RL; Green LM; Berical A; Wang Y; Casali M; Streeck H; Bloom AK; Dudek T; Tully D; Newman R; Axten KL; Gladden AD; Battis L; Kemper M; Zeng Q; Shea TP; Gujja S; Zedlack C; Gasser O; Brander C; Hess C; Günthard HF; Brumme ZL; Brumme CJ; Bazner S; Rychert J; Tinsley JP; Mayer KH; Rosenberg E; Pereyra F; Levin JZ; Young SK; Jessen H; Altfeld M; Birren BW; Walker BD; Allen TM
    PLoS Pathog; 2012; 8(3):e1002529. PubMed ID: 22412369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.
    Koizumi H; Hashimoto M; Fujiwara M; Murakoshi H; Chikata T; Borghan MA; Hachiya A; Kawashima Y; Takata H; Ueno T; Oka S; Takiguchi M
    J Virol; 2010 Jun; 84(11):5508-19. PubMed ID: 20335254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.